MTOR and acute lymphoblastic leukemia: In this paper, we demonstrate that rapamycin can re-sensitize GC-resistant T-ALL cells to Dex-induced apoptosis and explore the potential therapeutic use of the selective mTOR inhibitor rapamycin for GC-resistant T-ALLs.